Hiroki Tsukada

Successful Efavirenz Dose Reduction in HIV Type 1-Infected Individuals with Cytochrome P450 2B6 *6 and *26

Hiroyuki Gatanaga, Tsunefusa Hayashida, K. Tsuchiya et al. · Clinical Infectious Diseases · 2007 · 222 citations

Medicine, Pharmacokinetics, Pharmacology +17

Haemophilus parainfluenzae antigen and antibody in renal biopsy samples and serum of patients with IgA nephropathy

S. Suzuki, Hirokazu Sato, Hiroki Tsukada et al. · The Lancet · 1994 · 164 citations

Medicine, Immunology, Nephrology +13

JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy – The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG

Keiichi Mikasa, Nobuki Aoki, Yosuke Aoki et al. · Journal of Infection and Chemotherapy · 2016 · 109 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

IFN-γ-producing ability as a possible marker for the protective T cells against Mycobacterium bovis BCG in mice

Ikuo Kawamura, Hiroki Tsukada, Hideshi Yoshikawa et al. · The Journal of Immunology · 1992 · 79 citations

Life Sciences, Immunology, Infectious Diseases +17

Nationwide surveillance of bacterial respiratory pathogens conducted by the Surveillance Committee of Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Clinical Microbiology in 2009: general view of the pathogens’ antibacterial susceptibility

Akira Watanabe, Katsunori Yanagihara, Tetsuya Matsumoto et al. · Journal of Infection and Chemotherapy · 2012 · 76 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +16